A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer

Author:

Lin Hui-Ming12ORCID,Mahon Kate L.1234,Weir Jacquelyn M.5,Mundra Piyushkumar A.5,Spielman Calan1,Briscoe Karen6,Gurney Howard7,Mallesara Girish8,Marx Gavin9,Stockler Martin R.341011,PRIMe Consortium 12,Parton Robert G.13,Hoy Andrew J.14,Daly Roger J.15,Meikle Peter J.5,Horvath Lisa G.123411

Affiliation:

1. Cancer Division; The Kinghorn Cancer Centre/Garvan Institute of Medical Research; Darlinghurst NSW Australia

2. St Vincent's Clinical School, UNSW Sydney; NSW Australia

3. Medical Oncology; Chris O'Brien Lifehouse; Camperdown NSW Australia

4. Royal Prince Alfred Hospital; Camperdown NSW Australia

5. Metabolomics Laboratory; Baker IDI Heart and Diabetes Institute; Melbourne VIC Australia

6. Medical Oncology; Mid North Coast Cancer Institute, Coffs Harbour Health Campus; Coffs Harbour NSW Australia

7. Medical Oncology; Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead NSW Australia

8. Medical Oncology; Calvary Mater Newcastle; Waratah NSW Australia

9. Medical Oncology; Sydney Adventist Hospital; Wahroonga NSW Australia

10. Medical Oncology; Concord Repatriation General Hospital; Concord NSW Australia

11. Sydney Medical School, The University of Sydney; Camperdown NSW Australia

12. Pharmacogenomics Research for Individualised Medicine Consortium; NSW Australia

13. Cell Biology and Molecular Medicine Division; Institute for Molecular Bioscience, University of Queensland; Brisbane QLD Australia

14. Discipline of Physiology; School of Medical Sciences & Bosch Institute, Charles Perkins Centre, The University of Sydney; Camperdown NSW Australia

15. Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology; Monash University; Clayton VIC Australia

Funder

National Health and Medical Research Council

State Government of Victoria

Cancer Institute NSW

Cancer Council NSW

Prostate Cancer Foundation of Australia

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Overview of the latest treatments for castration-resistant prostate cancer;Bishr;Nat Rev Urol,2013

2. Obesity and prostate cancer: weighing the evidence;Allott;Eur Urol,2013

3. Lipid metabolism in prostate cancer;Wu;Am J Clin Exp Urol,2014

4. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis;Menendez;Nat Rev Cancer,2007

5. Principles of bioactive lipid signalling: lessons from sphingolipids;Hannun;Nat Rev Mol Cell Biol,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3